<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <label>26</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mennini</surname>
    <given-names>F. S.</given-names>
   </name>
   <name>
    <surname>Bini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Marcellusi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rinaldi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Franco</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy</article-title>
  <source>
   <italic toggle="yes">Human Vaccines &amp; Immunotherapeutics</italic>
  </source>
  <year>2018</year>
  <volume>14</volume>
  <issue>8</issue>
  <fpage>1867</fpage>
  <lpage>1873</lpage>
  <pub-id pub-id-type="doi">10.1080/21645515.2018.1469368</pub-id>
  <pub-id pub-id-type="pmid">29708843</pub-id>
 </element-citation>
</ref>
